Navigation Links
MEDRAD® Announces New Head of Interventional Business
Date:3/29/2011

WARRENDALE, Pa., March 29, 2011 /PRNewswire/ -- Today MEDRAD, INC. announced that Jack Darby has joined the company as vice president of MEDRAD Interventional. In his new role, Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and will also join MEDRAD's executive leadership team.  

(Photo:  http://photos.prnewswire.com/prnh/20110329/NE73380 )

(Logo: http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO)

Darby brings almost 20 years of experience in the medical device industry to the role, with most of those years in the interventional cardiology space. He comes to MEDRAD from AGA Medical Corporation, where he most recently served as senior vice president of Global Marketing and Distributor Sales, gaining deep experience in the field of the structural heart. Prior to AGA, Darby spent over 15 years at Cordis, a Johnson & Johnson company, starting as an angiographic sales representative. His leadership ability, sales/marketing acumen and international experience ultimately resulted in his role as vice president of commercial operations and global stent marketing.

"Jack's broad base of experience in the interventional space and combination drug-device products will greatly complement our patient-focused goals for the interventional business," says MEDRAD President and CEO Sam Liang. "With the support of his leadership, we plan to extend our product innovation and customer satisfaction footprint within this growing, global market."

With manufacturing facilities in both Minneapolis, MN and Pittsburgh, PA, MEDRAD Interventional manufactures and markets segment-leading medical devices such as AngioJet® Thrombectomy Systems, MEDRAD Avanta® Fluid Management Injector Systems and catheters, Mark V ProVis® Angiographic Contrast Injectors, FETCH® Aspiration Catheters and the GuardDOG® Occlusion System.

About MEDRAD, INC.

MEDRAD, INC. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD is a two-time recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence (2003 and 2010). The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer HealthCare. More company information is available at www.medrad.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Forward-looking statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


'/>"/>
SOURCE MEDRAD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
2. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
3. Boston Scientific Announces Its ACC 2011 Schedule
4. Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements
5. Dendreon Announces Webcast Presentations at Upcoming Conferences
6. Diversified Medical Equipment & Supplies Corporation Announces New Home Care Medical Supply Division
7. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
8. JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement
9. Ascension Orthopedics Announces Market Release of TITAN™ Modular Shoulder Fracture Prosthesis
10. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
11. Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... 2017 The Galien Foundation announced today ... USA Award Nominees. Counted among the global health ... outstanding biomedical and technology product achievement that improves the human ... each candidate must be U.S. Food and Drug Administration (FDA) ... tremendous potential to impact human health. Sales data are not ...
(Date:7/24/2017)... 24, 2017 IBM (NYSE: IBM ) has ... for Solid-State Arrays (SSA) for the fourth year in a ... to Gartner, "Vendors in the Leaders quadrant have the highest ... A vendor in the Leaders quadrant has the market share, ... acceptance of new technologies. These vendors demonstrate a clear understanding ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
Breaking Medicine Technology:
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... July 27, 2017 , ... MAP ... in this year’s Fierce Innovation Awards: Healthcare Edition 2017, an awards program from ... category of Population Health Management/Patient Engagement Solutions. , MAP was selected as ...
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., knows ... yet seen an effective and dignified way to keep leeches in place during therapy," ... , This invention provides an effective way to keep a leech in place on ...
(Date:7/26/2017)... ... ... A major challenge many labs face is a direct result from a ... dry cycle are a few common challenges that can overcome when following best practices. ... and advancements in laboratory freeze dryers that will improve quality and reduce the time ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... on-premises, off and in the cloud ; today announced the availability of its ... within a simple to use control console for Data Discovery, Classification, Encryption and ...
Breaking Medicine News(10 mins):